Bresser Cato C, Garvelink Mirjam M, van den Berg Birgitta M M, Dolk Franklin C K, van der Nat Paul B, van Melick Harm H E
Department of Urology, St. Antonius Hospital, Nieuwegein, The Netherlands; Department of Value Improvement, St. Antonius Hospital, Nieuwegein, The Netherlands; IQ Health, Radboudumc, Nijmegen, The Netherlands.
Department of Value Improvement, St. Antonius Hospital, Nieuwegein, The Netherlands; IQ Health, Radboudumc, Nijmegen, The Netherlands.
Eur Urol Oncol. 2025 Apr;8(2):245-248. doi: 10.1016/j.euo.2024.09.003. Epub 2024 Sep 20.
The aim of the SDM-RCC study is to evaluate the impact of a comprehensive shared decision-making (SDM) intervention for patients with renal cell carcinoma (RCC) on the decision-making process and outcomes. The intervention includes online patient decision aids (PtDAs) and training of health care professionals (HCPs) in the use of PtDAs and SDM. The study is a multicenter, prospective pretest-posttest cohort in six Dutch hospitals, focusing on patients with localized or metastatic RCC. The primary outcome is the observed quality of the decision-making process, measured using OPTION-5 scores. Secondary outcomes include perceived quality of the decision-making process, decision quality, and implementation of the intervention (user statistics and interviews). Quantitative analysis will be performed on questionnaire data, while qualitative analysis will be performed on interviews using coding based on established frameworks. The study results could improve understanding of the decision-making process for RCC patients from patient, HCP, and observer perspectives. The SDM tool implemented is expected to support the decision-making process. PATIENT SUMMARY: We are conducting a trial on the effects of a tool to support shared decision-making by patients with kidney cancer who are facing treatment decisions. This paper outlines the protocol that will be used for the trial.
SDM-RCC研究的目的是评估针对肾细胞癌（RCC）患者的全面共享决策（SDM）干预措施对决策过程和结果的影响。该干预措施包括在线患者决策辅助工具（PtDAs）以及对医护人员（HCPs）进行使用PtDAs和SDM的培训。该研究是一项在荷兰六家医院开展的多中心、前瞻性前后测队列研究，聚焦于局限性或转移性RCC患者。主要结局是使用OPTION-5评分衡量的观察到的决策过程质量。次要结局包括感知到的决策过程质量、决策质量以及干预措施的实施情况（用户统计数据和访谈）。将对问卷数据进行定量分析，而对访谈将使用基于既定框架的编码进行定性分析。研究结果有望从患者、医护人员和观察者的角度提高对RCC患者决策过程的理解。所实施的SDM工具预计将支持决策过程。患者摘要：我们正在对一种工具的效果进行试验，该工具用于支持面临治疗决策的肾癌患者进行共享决策。本文概述了将用于该试验的方案。
